"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada.
(Photo: AFP/Giuseppe Cacace)
Jul 30, 2015
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
An Unconstitutional Rampage
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Sarah Lazare
Sarah Lazare was a staff writer for Common Dreams from 2013-2016. She is currently web editor and reporter for In These Times.
canadapublic healthreproductive rightswomenabortion pillsabortion rightsnational abortion federationmifepristone
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
Sarah Lazare
Sarah Lazare was a staff writer for Common Dreams from 2013-2016. She is currently web editor and reporter for In These Times.
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.